Xenon Pharmaceuticals (NASDAQ:XENE – Get Free Report)‘s stock had its “overweight” rating reaffirmed by Cantor Fitzgerald in a research report issued to clients and investors on Wednesday, Benzinga reports. They presently have a $65.00 price objective on the biopharmaceutical company’s stock. Cantor Fitzgerald’s price target indicates a potential upside of 52.19% from the company’s current […]
Xenon Pharmaceuticals (NASDAQ:XENE – Get Free Report)‘s stock had its “overweight” rating restated by investment analysts at Cantor Fitzgerald in a report released on Wednesday, Benzinga reports. They currently have a $65.00 price target on the biopharmaceutical company’s stock. Cantor Fitzgerald’s price target would indicate a potential upside of 52.19% from the company’s current price. […]
China Universal Asset Management Co. Ltd. boosted its holdings in shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Free Report) by 417.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,546 shares of the biopharmaceutical company’s stock after buying an additional […]
SG Americas Securities LLC reduced its holdings in shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Free Report) by 67.2% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 18,606 shares of the biopharmaceutical company’s stock after selling 38,146 shares during the quarter. SG […]
Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Receives Average Recommendation of "Buy" from Analysts themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.